2023
-
Vlasenkova R, Konysheva D, Nurgalieva A, Kiyamova R. Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer//Diagnostics. - 2023. - Vol.13, Is.19. - Art. №3092.
-
Demidova E.V, Serebriiskii I.G, Vlasenkova R, Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing//BMC Genomics. - 2023. - Vol.24, Is.1. - Art. №212.
2022
-
Коротаева А.В. Распознавние Na-зависимого фосфатного транспортера NaPi2b моноклонла в клетках бактерий и эукариот
/ А.В. Коротаева , Л.Ф. Булатова, Р.А. Власенкова, Р.Г. Киямова // Биотехнология. - 2022. - Т. 138. – № 5. – С. 66-72.
Korotaeva66_72.pdf -
Skripova V. Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and Cisplatin // Vlasenkova, R., Zhou, Y., Astsaturov, I., Kiyamova, R. Molecules. - 2022. - Vol.27, Is.4. - Art. №1289. https://doi.org/10.3390/molecules27041289
2021
-
Vlasenkova R, Nurgalieva A, Akberova N, Characterization of slc34a2 as a potential prognostic marker of oncological diseases//Biomolecules. - 2021. - Vol.11, Is.12. - Art. №1878.
-
Nurgalieva A.K. Sodium-dependent phosphate transporter NaPi2b as a potential predictive marker for targeted therapy of ovarian cancer / Nurgalieva AK, Popov VE, Skripova VS, Bulatova LF, Savenkova DV, Vlasenkova RA, Safina SZ, Shakirova EZ, Filonenko VV, Bogdanov MV, Kiyamova RG. // Biochemistry and Biophysics Reports. - 2021. - Vol.28, Is.. - Art. №101104. doi: 10.1016/j.bbrep.2021.101104.
2019
-
Nicolas E, Demidova E.V, Iqbal W, Interaction of germline variants in a family with a history of early-onset clear cell renal cell carcinoma//Molecular Genetics and Genomic Medicine. - 2019. - Vol.7, Is.3. - Art. № e556.
-
Beck T.N, Boumber Y.A, Aggarwal C, Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer//BMC Cancer. - 2019. - Vol.19, Is.1. - Art. № 603.
2016
-
Beglyarova N, Banina E, Zhou Y, Screening of conditionally reprogrammed patient-derived carcinoma cells identifies ERCC3-MYC interactions as a target in pancreatic cancer//Clinical Cancer Research. - 2016. - Vol.22, Is.24. - P.6153-6163.
- Beglyarova, N. Screening of conditionally reprogrammed patient-derived carcinoma cells identifies ERCC3-MYC interactions as a target in pancreatic cancer / N. Beglyarova, E. Banina, Y. Zhou, R. Mukhamadeeva, G. Andrianov, E. Bobrov, E. Lysenko, N. Skobeleva, L. Gabitova, D. Restifo, M. Pressman, I.G. Serebriiskii, J.P Hoffman, K. Paz, D. Behrens, V. Khazak, S.A Jablonski, L.M. Weiner, E.A. Golemis, I. Astsaturov // Clinical Cancer Research. ? 2016. ? V.22(15). doi: 10.1158/1078-0432.CCR-16-0149
2012
| Рабочий адрес: | Казань, ул. Кремлевская, д. 18, Учебное здание №02 (Восточное крыло главного корпуса университета) |
| Номер кабинета: | 119в |
| E-mail: | r.mukhamadeeva@yandex.ru |
| Google scholar: | https://scholar.google.ru/citations?user=M3aMIysAAAAJ&hl |
| Стаж в КФУ: |
| Педагогический стаж (ППС) в ВУЗе: |
| Научно-педагогический стаж: |
| Общий стаж: |
| Непрерывный в КФУ: |
